Should selection of adjuvant chemotherapy for patients with breast cancer be based on erbB-2 status?
Clark
G M
GM
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000235:genetics*; D017024:Chemotherapy, Adjuvant; D005260:Female; D018734:Genes, erbB-2; D006801:Humans; D018579:Patient Selection